CARM1 and neoplasm: In this study, we found that administering SGC2085 markedly inhibited the proliferation, migration, and invasion of HCC cells in vitro and strongly suppressed tumor growth in vivo, suggesting that targeting CARM1 may be a promising treatment for HCC.